共 50 条
- [21] A phase II multicenter, double-blind, randomized trial to compare anastrozole plus gefinitib with anastrozole plus placebo in postmenopausal women with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Cristofanilli, M.Valero, V.Mangalik, A.Rabinowitz, I.Arena, F. P.Kroener, J. F.Curcio, E.Watkins, C.Magill, P.
- [22] Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trialJOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)Mariette, ChristopheMeunier, BernardPezet, DenisDalban, CecileCollet, DenisThomas, Pascal-AlexandreBrigand, CecilePerniceni, ThierryCarrere, NicolasBonnetain, FranckPiessen, Guillaume
- [23] Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III TrialJOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1774 - +Li, JunjieYu, KedaPang, DaWang, ChangqinJiang, JunYang, SuishengLiu, YunjiangFu, PeifenSheng, YuanZhang, GuojunCao, YaliHe, QiCui, ShudeWang, XijingRen, GuoshengLi, XinzhengYu, ShiyouLiu, PengxiQu, XiangTang, JinhaiWang, OuchenFan, ZhiminJiang, GuoqinZhang, JinWang, JiandongZhang, HongweiWang, ShuiZhang, JianguoJin, FengRao, NanyanMa, BinlinHe, PingqingXu, BingheZhuang, ZhigangWang, JianfengSun, QiangGuo, XiaofengMo, MiaoShao, Zhimin
- [24] Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 yearsJOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (04) : 249 - 256Wu, Chiao-EnChen, Shin-ChehChang, Hsien-KunLo, Yung-FengHsueh, SweiLin, Yung-Chang
- [25] The impact of food on tolerability of abemaciclib in patients with previously treated hormone receptor-positive, HER2-negative, metastatic breast cancer: An open-label, randomized phase 2 studyCANCER RESEARCH, 2020, 80 (04)Lim, ElgeneBoyle, FrancesOkera, MeenaLoi, ShereneGoksu, Sema Sezginvan Hal, GertjanHartman, Daisy G.Gable, Jonathon ColbyPrice, Gregory L.Hossain, AnwarGainford, M. C.Ezquerra, Meritxell Bellet
- [26] The impact of food on tolerability of abemaciclib in patients with previously treated hormone receptor-positive, HER2-negative, metastatic breast cancer: An open-label, randomized phase 2 studyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 124 - 125Lim, ElgeneBoyle, FrancesOkera, MeenaLoi, ShereneGoksu, Sema S.van Hal, GertjanGable, Jonathon C.Price, Gregory L.Hossain, AnwarGainford, MaryEzquerra, Meritxell B.
- [27] Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trialBREAST, 2023, 68 : S16 - S16Cao, F.Ma, Z.Hu, G.Zhu, X.Li, S.Chen, S.Chen, B.Li, Z.Wu, W.Ji, X.Shu, J.Tao, D.Hu, X.Zheng, M.Wang, O.Feng, Q.Hao, J.Li, X.
- [28] E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancerNPJ BREAST CANCER, 2018, 4Yeruva, Sri Lakshmi HyndaviZhao, FengminMiller, Kathy D.Tevaarwerk, Amye J.Wagner, Lynne I.Gray, Robert J.Sparano, Joseph A.Connolly, Roisin M.
- [29] E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancernpj Breast Cancer, 4Sri Lakshmi Hyndavi YeruvaFengmin ZhaoKathy D. MillerAmye J. TevaarwerkLynne I. WagnerRobert J. GrayJoseph A. SparanoRoisin M. Connolly
- [30] Randomized phase 3 trial of adjuvant letrozole versus anastrozole in postmenopausal patients with hormone receptor positive, node positive early breast cancer: Final efficacy and safety results of the femara versus anastrozole clinical evaluation (Face) trialCANCER RESEARCH, 2016, 76O'Shaughnessy, J.Yardley, D. A.Burris, H. A.De Boer, R.Amadori, D.McIntyre, K.Ejlertsen, B.Gnant, M.Jonat, W.Pritchard, K. I.Dowsett, M.Hart, L.Poggio, S.Valagussa, P.Salomon, H.Wamil, B.Smith, I.